Literature DB >> 31312406

High Affinity Fluorescent Probe for Proteinase-Activated Receptor 2 (PAR2).

Jordan C LeSarge1, Pierre Thibeault1, Mark Milne2, Rithwik Ramachandran1, Leonard G Luyt1,1,1,2.   

Abstract

PAR2 is a proteolytically activated G protein-coupled receptor (GPCR) that is implicated in various cancers and inflammatory diseases. Ligands with low nanomolar affinity for PAR2 have been developed, but there is a paucity of research on the development of PAR2-targeting imaging probes. Here, we report the development of seven novel PAR2-targeting compounds. Four of these compounds are highly potent and selective PAR2-targeting peptides (EC50 = 10 to 23 nM) that have a primary amine handle available for facile conjugation to various imaging components. We describe a peptide of the sequence Isox-Cha-Chg-ARK(Sulfo-Cy5)-NH2 as the most potent and highest affinity PAR2-selective fluorescent probe reported to date (EC50 = 16 nM, K D = 38 nM). This compound has a greater than 10-fold increase in potency and binding affinity for PAR2 compared to the leading previously reported probe and is conjugated to a red-shifted fluorophore, enabling in vitro and in vivo studies.

Entities:  

Year:  2019        PMID: 31312406      PMCID: PMC6627725          DOI: 10.1021/acsmedchemlett.9b00094

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  38 in total

1.  Induction of intestinal inflammation in mouse by activation of proteinase-activated receptor-2.

Authors:  Nicolas Cenac; Anne-Marie Coelho; Cathy Nguyen; Steven Compton; Patricia Andrade-Gordon; Wallace K MacNaughton; John L Wallace; Morley D Hollenberg; Nigel W Bunnett; Rafael Garcia-Villar; Lionel Bueno; Nathalie Vergnolle
Journal:  Am J Pathol       Date:  2002-11       Impact factor: 4.307

2.  Binding of a highly potent protease-activated receptor-2 (PAR2) activating peptide, [3H]2-furoyl-LIGRL-NH2, to human PAR2.

Authors:  Toru Kanke; Hiroyuki Ishiwata; Mototsugu Kabeya; Masako Saka; Takeshi Doi; Yukio Hattori; Atsufumi Kawabata; Robin Plevin
Journal:  Br J Pharmacol       Date:  2005-05       Impact factor: 8.739

3.  A protective role for protease-activated receptors in the airways.

Authors:  T M Cocks; B Fong; J M Chow; G P Anderson; A G Frauman; R G Goldie; P J Henry; M J Carr; J R Hamilton; J D Moffatt
Journal:  Nature       Date:  1999-03-11       Impact factor: 49.962

4.  Protease-activated receptor-2 (PAR-2): structure-function study of receptor activation by diverse peptides related to tethered-ligand epitopes.

Authors:  B E Maryanoff; R J Santulli; D F McComsey; W J Hoekstra; K Hoey; C E Smith; M Addo; A L Darrow; P Andrade-Gordon
Journal:  Arch Biochem Biophys       Date:  2001-02-15       Impact factor: 4.013

5.  Proteinase-activated receptor 2 (PAR(2)): development of a ligand-binding assay correlating with activation of PAR(2) by PAR(1)- and PAR(2)-derived peptide ligands.

Authors:  B Al-Ani; M Saifeddine; A Kawabata; B Renaux; S Mokashi; M D Hollenberg
Journal:  J Pharmacol Exp Ther       Date:  1999-08       Impact factor: 4.030

6.  A major role for proteolytic activity and proteinase-activated receptor-2 in the pathogenesis of infectious colitis.

Authors:  Kristina K Hansen; Philip M Sherman; Laurie Cellars; Patricia Andrade-Gordon; Zhengying Pan; Amos Baruch; John L Wallace; Morley D Hollenberg; Nathalie Vergnolle
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-26       Impact factor: 11.205

7.  2-furoyl-LIGRLO-amide: a potent and selective proteinase-activated receptor 2 agonist.

Authors:  John J McGuire; Mahmoud Saifeddine; Chris R Triggle; Kimberly Sun; Morley D Hollenberg
Journal:  J Pharmacol Exp Ther       Date:  2004-02-19       Impact factor: 4.030

8.  Protease-activated receptors (PAR1 and PAR2) contribute to tumor cell motility and metastasis.

Authors:  Xiaoli Shi; Beena Gangadharan; Lawrence F Brass; Wolfram Ruf; Barbara M Mueller
Journal:  Mol Cancer Res       Date:  2004-07       Impact factor: 5.852

9.  Protease-activated receptor (PAR)-1 and PAR-2 participate in the cell growth of alveolar capillary endothelium in primary lung adenocarcinomas.

Authors:  Enjing Jin; Masakazu Fujiwara; Xin Pan; Mohammad Ghazizadeh; Satoru Arai; Yoshiharu Ohaki; Keiko Kajiwara; Tamiko Takemura; Oichi Kawanami
Journal:  Cancer       Date:  2003-02-01       Impact factor: 6.860

10.  Essential role for proteinase-activated receptor-2 in arthritis.

Authors:  William R Ferrell; John C Lockhart; Elizabeth B Kelso; Lynette Dunning; Robin Plevin; Stephen E Meek; Andrew J H Smith; Gary D Hunter; John S McLean; Frances McGarry; Robert Ramage; Lu Jiang; Toru Kanke; Junichi Kawagoe
Journal:  J Clin Invest       Date:  2003-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.